Live research Q&A with Prof Martin Widschwendter

This week, research supported by The Eve Appeal was published in Nature
Communications showing promise that one day cervical screening tests could
potentially help screen for breast and ovarian cancer.

The research, led by Prof Martin Widschwendter, aims to develop one screening test
for four key cancers that affect women and people with gynaecological organs-
breast, womb, ovarian and cervical.

The research shows promising first results about the tests’ ability to detect breast
and ovarian cancer- it found up to 30% more women with these cancers than current
genetic-based tests. The new test (called the WID-Test) looks beyond cancer
genetics, and into how each person responds to environmental and lifestyle factors
which can increase or decrease the risk of developing cancer.

By bringing these factors together, the researchers are aiming to develop the WID-
Test as a screening programme that predicts the risk of these four cancers from a
cervical screening sample, to enable people to take steps to help prevent cancer
from developing.

Today we speak to Prof Martin Widschwendter and Dr Chiara Herzog about the
news and ask them all of your pressing questions.

#CancerResearch #CancerScreening #OvarianCancer #BreastCancer
#CervicalScreening #Research #EveAppeal #TheEveAppeal